Susquehanna International Securities, Ltd. Haleon PLC Transaction History

Susquehanna International Securities, Ltd.

$389 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.78 - $8.62 $903,755 - $1 Million	116,164 Added 106.89%	224,841 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $94,529 - $107,655	-12,042 Reduced 9.98%	108,677 $905,000
Q2 2023 Aug 11, 2023	BUY	$8.04 - $9.0 $970,580 - $1.09 Million	120,719 New	120,719 $1.01 Million

Others Institutions Holding HLN

# of Institutions

660

Shares Held

432M

Call Options Held

269K

Put Options Held

40.6K

Dodge & Cox San Francisco, CA

179M
Shares

$1.8 Billion
1.07% of portfolio
Clearbridge Investments, LLC New York, NY

32.8M
Shares

$331 Million
0.26% of portfolio
Harding Loevner LP Bridgewater, NJ

24.1M
Shares

$243 Million
1.6% of portfolio
Wellington Management Group LLP Boston, MA

15.3M
Shares

$155 Million
0.03% of portfolio
Morgan Stanley New York, NY

9.89M
Shares

$99.7 Million
0.01% of portfolio

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $46.5B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Account